ONC

BeOne Medicines Ltd. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-26

Figures on this page computed 2026-11-08 12:40 UTC

Last close

377.78USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-26

2034.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001628280-26-011946
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
33.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001628280-26-011946
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
The filing itself
5.4%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-011946
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
17.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-011946
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
0.25Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001628280-26-011946
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-05
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.01 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

3.47x

-0.35x

-1.21x

1.73x

1.89x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales3.47x
Its own average over 10 years, 1.54B.
Profit-0.35x
Its own average over 10 years, -816.1M.
Free cash flow-1.21x
Its own average over 10 years, -780.0M.
Debt1.73x
Its own average over 10 years, 638.4M.
Price1.89x
Its own average over 11 years, 200. Market data, 2026-11-04

Sales is furthest from its own average, at 3.47 times.

Sales is 3.47 times its own 10-year average; Profit is -0.35 times its own 10-year average; Free cash flow is -1.21 times its own 10-year average; Debt is 1.73 times its own 10-year average; Price is 1.89 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales against its own 10-year average3.47
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-011946
Reported in
USD
The filing itself
Profit against its own 10-year average-0.35
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-011946
Reported in
USD
The filing itself
Free cash flow against its own 10-year average-1.21
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-011946
Reported in
USD
The filing itself
Debt against its own 10-year average1.73
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-011946
Reported in
USD
The filing itself
Price against its own 11-year average1.89Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD